Tenofovir disoproxil fumarate: Phase II data; Phase III

In a Phase II study of 189 treatment-experienced HIV patients, 48-week data showed mean reductions in viral load of 0.62, 0.58 and 0.4 log HIV RNA copies/mL in patients receiving 300, 150 or 75 mg ten...